Publications

Doc 04 sets out essential information necessary and the relevant protective measures that should be taken to prevent fire hazards resulting from handling oxygen. An appendix provides a summary of the information in the publication that can be reproduced as a pamphlet to be handed to those involved in daily operations involving oxygen or be used as a supplement to safety presentations. A second appendix lists some incidents that have taken place in recent years and can be used as examples underlining the hazards of oxygen and oxygen-enriched atmospheres.

EIGA urges the EU Commission to take this finding into account also in the context of the 2025 update of the ETS State Aid guidelines and consider extending indirect emission cost compensation to the entire industrial gas sector.

EIGA urges the European Commission to proceed with the necessary regulatory adjustments so that the LPF will be restored, i.e. by ensuring that hydrogen outsourced by refineries or organic chemical installations receives the same level of FAs as if such installations would insource the production of hydrogen they consume. EIGA therefore urges the European Commission to proceed with the necessary regulatory adjustments so that the LPF will be restored, i.e. by ensuring that hydrogen outsourced by refineries or organic chemical installations receives the same level of FAs as if such installations would insource the production of hydrogen they consume.

EIGA and 16 other signatories have released a joint statement on the 𝘂𝗿𝗴𝗲𝗻𝘁 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗰𝗼𝗿𝗿𝗲𝗰𝘁 𝗰𝗼𝘂𝗿𝘀𝗲 𝗼𝗻 𝘁𝗵𝗲 𝗱𝗿𝗮𝗳𝘁 𝗗𝗲𝗹𝗲𝗴𝗮𝘁𝗲𝗱 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝗟𝗼𝘄 𝗖𝗮𝗿𝗯𝗼𝗻 𝗙𝘂𝗲𝗹𝘀. EIGA and 16 other associations representing the whole energy value chain are calling on the Commission to 𝗲𝗻𝘀𝘂𝗿𝗲 𝘁𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗲𝗻𝗮𝗯𝗹𝗲𝘀 𝘁𝗵𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗶𝗺𝗽𝗼𝗿𝘁 𝗼𝗳 𝗮𝗹𝗹 𝘁𝘆𝗽𝗲𝘀 𝗼𝗳 𝗹𝗼𝘄-𝗰𝗮𝗿𝗯𝗼𝗻 𝗵𝘆𝗱𝗿𝗼𝗴𝗲𝗻, and 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘀𝗲𝘀 𝘄𝗵𝗲𝗻 𝗽𝗿𝗼𝗱𝘂𝗰𝗲𝗿𝘀 𝗰𝗮𝗻 𝗮𝗰𝗵𝗶𝗲𝘃𝗲 𝗯𝗲𝘁𝘁𝗲𝗿 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁𝗮𝗹 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲. This is critical for supporting the scaleup of the hydrogen market in Europe, which already faces major challenges that undermine the EU's ability to meet its climate objectives.

This White Paper on medicinal oxygen provides a comprehensive overview of the use of oxygen, its properties, historical significance, and its various applications, specifically in the medical field. Its prime purpose is to consider the different medical oxygen supply sources used for Medical Gas Pipeline Systems (MGPS) in Healthcare Facilities (HF), but to also include information about the development of oxygen as a medicinal product and an overview of its physical properties

EIGA and 16 other industry associations representing the hydrogen value chain call for an urgent adjustment of the European hydrogen policy.

EIGA consistently uphold three fundamental principles: uncompromised safety, level-playing field and solid expertise. Here are our calls to the EU Institutions for 2024-2029

To ensure standard outcomes regardless of the method of delivery, EIGA requests competent authorities harmonised guidance for the on-site production of medicinal gases in the forthcoming revision of the EU’s General Pharmaceutical Legislation

EIGA and 16 other industry associations provided recommendations to the European Commission on the upcoming certification of low-carbon fuels.

To ensure patient safety EIGA requests the competent authorities to harmonised guidance on how to apply consistently both the medical device and the medical product regulations for on-site medicinal gas extemporaneous preparations.